| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 17.944 | 5.530 | 11.757 | 32.773 | 32.990 | 29.426 |
| Total Income - EUR | - | - | - | - | 17.978 | 5.530 | 11.757 | 32.773 | 53.646 | 29.523 |
| Total Expenses - EUR | - | - | - | - | 13.426 | 4.353 | 9.896 | 28.601 | 37.254 | 25.537 |
| Gross Profit/Loss - EUR | - | - | - | - | 4.552 | 1.177 | 1.861 | 4.172 | 16.392 | 3.986 |
| Net Profit/Loss - EUR | - | - | - | - | 4.286 | 1.121 | 1.639 | 3.844 | 15.937 | 3.735 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bioband Barbu S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 18.164 | 13.031 | 261 | 6.821 |
| Current Assets | - | - | - | - | 6.047 | 5.366 | 8.004 | 9.740 | 22.415 | 11.918 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 2.509 | 7 | 3.098 | 7.619 | 3.594 | 3.856 |
| Cash | - | - | - | - | 3.538 | 5.359 | 4.906 | 2.121 | 18.820 | 8.062 |
| Shareholders Funds | - | - | - | - | 4.328 | 5.366 | 6.887 | 4.669 | 20.591 | 17.009 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.719 | 0 | 19.281 | 18.102 | 2.084 | 1.730 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Bioband Barbu S.r.l.